Radiotherapy-induced signal transduction

Endocrine-Related Cancer

Volumn 13, Issue SUPPL. 1, 2006, Pages

  Yacoub, Adly ^a   Miller, Anna ^a   Caron, Ruben W ^d   Qiao, Liang ^e   Curiel, David A ^g   Fisher, Paul B ^f   Hagan, Michael P ^a   Grant, Steven ^a,b   Dent, Paul ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d College of Physicians and Surgeons ^*  (Argentina)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f New York Presbyterian Columbia University Medical Center   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; RAS PROTEIN;

CANCER RADIOTHERAPY; CELL SURVIVAL; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HUMAN; HUMAN CELL; IONIZING RADIATION; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIOSENSITIVITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

APOPTOSIS; HCT116 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; NEOPLASMS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 33846877176     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01271     Document Type: Conference Paper

References (37)

1. Baba I, Shirasawa S, Iwamoto R, Okumura K, Tsunoda T, Nishioka M, Fukuyama K, Yamamoto K, Mekada E & Sasazuki T 2000 Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Research 60 6886-6889.
2. Balmanno K, Millar T, McMahon M & Cook SJ 2003 DeltaRaf-1:ER* bypasses the cyclic AMP block of extracellular signal-regulated kinase 1 and 2 activation but not CDK2 activation or cell cycle reentry. Molecular and Cellular Biology 23 9303-9317.
3. Blalock WL, Navolanic PM, Steelman LS, Shelton JG, Moye PW, Lee JT, Franklin RA, Mirza A, McMahon M, White MK et al. 2003 Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Leukemia 17 1058-1067.
4. Caron RW, Yacoub A, Li M, Zhu X, Mitchell C, Hong Y, Hawkins W, Sasazuki T, Shirasawa S, Kozikowski AP et al. 2005a Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. Molecular Cancer Therapeutics 4 257-270.
5. Caron RW, Yacoub A, Zhu X, Mitchell C, Han SI, Sasazuki T, Shirasawa S, Hagan MP, Grant S & Dent P 2005b H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent. Molecular Cancer Therapeutics 4 243-255.
6. Cox AD & Der CJ 2003 The dark side of Ras: regulation of apoptosis. Oncogene 22 8999-9006.
7. Dent P, Jelinek T, Morrison DK, Weber MJ & Sturgill TW 1995a Reversal of Raf-1 activation by purified and membrane-associated protein phosphatases. Science 268 1902-1906.
8. Dent P, Reardon DB, Morrison DK & Sturgill TW 1995b Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro. Molecular and Cellular Biology 15 4125-4135.
9. Dent P, Reardon DB, Park JS, Bowers G, Logsdon C, Valerie K & Schmidt-Ullrich R 1999 Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Molecular Biology of the Cell 10 2493-2506.
10. Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S & Schmidt-Ullrich R 2003a Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiation Research 159 283-300.
11. Dent P, Yacoub A, Fisher PB, Hagan MP & Grant S 2003b MAPK pathways in radiation responses. Oncogene 22 5885-5896.
12. Ellis CA & Clark G 2000 The importance of being K-RAS. Cellular Signalling 12 425-434.
13. Fanton CP, McMahon M & Pieper RO 2001 Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation. Journal of Biological Chemistry 276 18871-18877.
14. Goldkorn T, Balaban N, Shannon M & Matsukuma K 1997 EGF receptor phosphorylation is affected by ionizing radiation. Biochimica et Biophysica Acta 1358 289-299.
15. Grant S, Fisher PB & Dent P 2002a The role of signal transduction pathways in drug and radiation resistance. Cancer Treatment and Research 112 89-108.
16. Grant S, Qiao L & Dent P 2002b Roles of ERBB family receptor tyrosine kinases and downstream signaling pathways in the control of cell growth and survival. Frontiers in Bioscience 7 376-389.
17. Hagan MP, Yacoub A & Dent P 2004 Ionizing radiation causes a dose-dependent release of the growth factor TGFα in vitro, from irradiated xenografts, and during the palliative treatment of patients suffering from hormone refractory prostate carcinoma. Clinical Cancer Research 10 5724-5731.
18. Hellyer NJ, Kim MS & Koland JG 2001 Heregulin-dependent activation of phosphoinositide 3-kinase and AKT via the ERBB2/ERBB3 co-receptor. Journal of Biological Chemistry 276 42153-42161.
19. Leach JK, Van Tuyle G, Lin PS, Schmidt-Ullrich R & Mikkelsen RB 2001 Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Research 61 3894-3901.
20. Liebmann C 2001 Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cellular Signalling 13 777-785.
21. Ludde T, Kubicka S, Plumpe J, Liedtke C, Manns MP & Trautwein C 2001 RAS adenoviruses modulate cyclin E protein expression and DNA synthesis after partial hepatectomy. Oncogene 20 5264-5278.
22. Moriuchi A, Hirono S, Ido A, Ochiai T, Nakama T, Uto H, Hori T, Hayashi K & Tsubouchi H 2001 Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes. Biochemical and Biophysical Research Communications 280 368-373.
23. Pruitt K & Der CJ 2001 RAS and Rho regulation of the cell cycle and oncogenesis. Cancer Letters 171 1-10.
24. Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F & Klocker H 1999 Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Cancer Research 59 227-233.
25. Reusen HP, Zimmermann S, Schaefer M, Paul M & Moelling K 2001 Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. Journal of Biological Chemistry 276 33630-33637.
26. Reuther GW & Der CJ 2000 The RAS branch of small GTPases: RAS family members don't fall far from the tree. Current Opinion in Cell Biology 12 157-165.
27. Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M & McCormick F 2000 Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 103 321-330.
28. Ross PJ, George M, Cunningham D, DiStefano F, Andreyev HJN, Workman P & Clarke PA 2001 Inhibition of Kirsten RAS expression in human colorectal cancer using rationally selected Kirsten-RAS antisense oligonucleotides. Molecular Cancer Therapeutics 1 29-41.
29. Schmidt-Ullrich RK, Valerie KC, Chan W & McWilliams D 1994 Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. International Journal of Radiation Oncology, Biology, Physics 29 813-819.
30. Schmidt-Ullrich RK, Contessa JN, Dent P, Mikkelsen RB, Valerie K, Reardon DB, Bowers G & Lin PS 1999 Molecular mechanisms of radiation-induced accelerated repopulation. Radiation Oncology Investigations 7 321-330.
31. Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB & Valerie K 2000 Signal transduction and cellular radiation responses. Radiation Research 153 245-257.
32. Shirasawa S, Furuse M, Yokoyama N & Sasazuki T 1993 Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260 85-88.
33. Sizemore N, Cox AD, Barnard JA, Oldham SM, Reynolds ER, Der CJ & Coffey RJ 1999 Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptides. Gastroenterology 117 567-576.
34. Sklar MD 1988 The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 239 645-647.
35. Sturla LM, Amorino G, Alexander MS, Mikkelsen RB, Valerie K & Schmidt-Ullrich RK 2005 Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2. Journal of Biological Chemistry 280 14597-14604.
36. Tomic S, Greiser U, Lammers R, Kharitonenkov A, Imyanitov E, Ullrich A & Bohmer F-D 1995 Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C. Journal of Biological Chemistry 270 21277-21284.
37. Yan J, Roy S, Apolloni A, Lane A & Hancock JF 1998 RAS isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. Journal of Biological Chemistry 273 24052-24056.